Logo image of GCTK

GLUCOTRACK INC (GCTK) Stock Fundamental Analysis

USA - NASDAQ:GCTK - US45824Q8042 - Common Stock

6.08 USD
-0.38 (-5.88%)
Last: 11/4/2025, 7:11:51 PM
6.04 USD
-0.04 (-0.66%)
After Hours: 11/4/2025, 7:11:51 PM
Fundamental Rating

1

GCTK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 189 industry peers in the Health Care Equipment & Supplies industry. GCTK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GCTK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

GCTK had negative earnings in the past year.
GCTK had a negative operating cash flow in the past year.
In the past 5 years GCTK always reported negative net income.
GCTK had a negative operating cash flow in each of the past 5 years.
GCTK Yearly Net Income VS EBIT VS OCF VS FCFGCTK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -262.19%, GCTK is not doing good in the industry: 94.18% of the companies in the same industry are doing better.
The Return On Equity of GCTK (-389.10%) is worse than 80.95% of its industry peers.
Industry RankSector Rank
ROA -262.19%
ROE -389.1%
ROIC N/A
ROA(3y)-130.51%
ROA(5y)-147.55%
ROE(3y)-220.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTK Yearly ROA, ROE, ROICGCTK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5K -5K 10K 15K

1.3 Margins

GCTK does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTK Yearly Profit, Operating, Gross MarginsGCTK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 -20K -40K -60K -80K

More info and screens

4

2. Health

2.1 Basic Checks

The number of shares outstanding for GCTK has been increased compared to 1 year ago.
Compared to 5 years ago, GCTK has more shares outstanding
GCTK has a better debt/assets ratio than last year.
GCTK Yearly Shares OutstandingGCTK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2K 4K 6K 8K 10K
GCTK Yearly Total Debt VS Total AssetsGCTK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

2.2 Solvency

Based on the Altman-Z score of -22.86, we must say that GCTK is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of GCTK (-22.86) is worse than 90.48% of its industry peers.
GCTK has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
With a decent Debt to Equity ratio value of 0.03, GCTK is doing good in the industry, outperforming 69.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -22.86
ROIC/WACCN/A
WACCN/A
GCTK Yearly LT Debt VS Equity VS FCFGCTK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

2.3 Liquidity

GCTK has a Current Ratio of 3.27. This indicates that GCTK is financially healthy and has no problem in meeting its short term obligations.
GCTK has a better Current ratio (3.27) than 63.49% of its industry peers.
GCTK has a Quick Ratio of 3.27. This indicates that GCTK is financially healthy and has no problem in meeting its short term obligations.
GCTK's Quick ratio of 3.27 is fine compared to the rest of the industry. GCTK outperforms 68.78% of its industry peers.
Industry RankSector Rank
Current Ratio 3.27
Quick Ratio 3.27
GCTK Yearly Current Assets VS Current LiabilitesGCTK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M

More info and screens

0

3. Growth

3.1 Past

GCTK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 20.25%, which is quite impressive.
EPS 1Y (TTM)20.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.02%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GCTK Yearly Revenue VS EstimatesGCTK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 200K 400K 600K

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

GCTK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GCTK Price Earnings VS Forward Price EarningsGCTK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTK Per share dataGCTK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

GCTK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GLUCOTRACK INC

NASDAQ:GCTK (11/4/2025, 7:11:51 PM)

After market: 6.04 -0.04 (-0.66%)

6.08

-0.38 (-5.88%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.81%
Inst Owner Change0%
Ins Owners0.41%
Ins Owner Change0.04%
Market Cap5.47M
Revenue(TTM)N/A
Net Income(TTM)-26770000
AnalystsN/A
Price TargetN/A
Short Float %7.23%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.8
P/tB 0.8
EV/EBITDA N/A
EPS(TTM)-2312.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-15.96
FCFYN/A
OCF(TTM)-15.92
OCFYN/A
SpS0
BVpS7.64
TBVpS7.64
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -262.19%
ROE -389.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-130.51%
ROA(5y)-147.55%
ROE(3y)-220.48%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 97.67%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.27
Quick Ratio 3.27
Altman-Z -22.86
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)5.42%
Cap/Depr(5y)35.05%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.02%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-254.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-253.85%
OCF growth 3YN/A
OCF growth 5YN/A

GLUCOTRACK INC / GCTK FAQ

What is the ChartMill fundamental rating of GLUCOTRACK INC (GCTK) stock?

ChartMill assigns a fundamental rating of 1 / 10 to GCTK.


Can you provide the valuation status for GLUCOTRACK INC?

ChartMill assigns a valuation rating of 0 / 10 to GLUCOTRACK INC (GCTK). This can be considered as Overvalued.


What is the profitability of GCTK stock?

GLUCOTRACK INC (GCTK) has a profitability rating of 0 / 10.


How sustainable is the dividend of GLUCOTRACK INC (GCTK) stock?

The dividend rating of GLUCOTRACK INC (GCTK) is 0 / 10 and the dividend payout ratio is 0%.